Post
CNBC
cnbc.com
did:plc:m7ks2xhfuku7errrtfjux2lg
The FDA has refused to start a review of Moderna’s application for its experimental flu shot, the company announced Tuesday, in another sign of the Trump administration’s influence on tightening vaccine regulations in the U.S. cnb.cx/4apcV7U
2026-02-11T16:39:15.155Z